Cargando…
Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: A protocol for a clustered, randomized clinical trial
BACKGROUND: Although benzodiazepines are effective, long-term use is not recommended because of potential adverse effects; the risks of tolerance and dependence; and an increased risk of hip fractures, motor vehicle accidents, and memory impairment. The estimated prevalence of long-term benzodiazepi...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105938/ https://www.ncbi.nlm.nih.gov/pubmed/21507257 http://dx.doi.org/10.1186/1471-2296-12-23 |
_version_ | 1782204743268958208 |
---|---|
author | Vicens, Caterina Socias, Isabel Mateu, Catalina Leiva, Alfonso Bejarano, Ferran Sempere, Ermengol Basora, Josep Palop, Vicente Mengual, Marta Beltran, Jose Luis Aragonès, Enric Lera, Guillem Folch, Silvia Piñol, Josep Lluís Esteva, Magdalena Roca, Miguel Arenas, Arturo del Mar Sureda, María Campoamor, Francisco Fiol, Francisca |
author_facet | Vicens, Caterina Socias, Isabel Mateu, Catalina Leiva, Alfonso Bejarano, Ferran Sempere, Ermengol Basora, Josep Palop, Vicente Mengual, Marta Beltran, Jose Luis Aragonès, Enric Lera, Guillem Folch, Silvia Piñol, Josep Lluís Esteva, Magdalena Roca, Miguel Arenas, Arturo del Mar Sureda, María Campoamor, Francisco Fiol, Francisca |
author_sort | Vicens, Caterina |
collection | PubMed |
description | BACKGROUND: Although benzodiazepines are effective, long-term use is not recommended because of potential adverse effects; the risks of tolerance and dependence; and an increased risk of hip fractures, motor vehicle accidents, and memory impairment. The estimated prevalence of long-term benzodiazepine use in the general population is about 2,2 to 2,6%, is higher in women and increases steadily with age. Interventions performed by General Practitioners may help patients to discontinue long-term benzodiazepine use. We have designed a trial to evaluate the effectiveness and safety of two brief general practitioner-provided interventions, based on gradual dose reduction, and will compare the effectiveness of these interventions with that of routine clinical practice. METHODS/DESIGN: In a three-arm cluster randomized controlled trial, general practitioners will be randomly allocated to: a) a group in which the first patient visit will feature a structured interview, followed by visits every 2-3 weeks to the end of dose reduction; b) a group in which the first patient visit will feature a structured interview plus delivery of written instructions to self-reduce benzodiazepine dose, or c) routine care. Using a computerized pharmaceutical prescription database, 495 patients, aged 18-80 years, taking benzodiazepine for at least 6 months, will be recruited in primary care health districts of three regions of Spain (the Balearic Islands, Catalonia, and Valencia). The primary outcome will be benzodiazepine use at 12 months. The secondary outcomes will include measurements of anxiety and depression symptoms, benzodiazepine dependence, quality of sleep, and alcohol consumption. DISCUSSION: Although some interventions have been shown to be effective in reducing benzodiazepine consumption by long-term users, the clinical relevance of such interventions is limited by their complexity. This randomized trial will compare the effectiveness and safety of two complex stepped care interventions with that of routine care in a study with sufficient statistical power to detect clinically relevant differences. TRIAL REGISTRATION: Current Controlled Trials: ISRCTN13024375 |
format | Text |
id | pubmed-3105938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31059382011-06-02 Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: A protocol for a clustered, randomized clinical trial Vicens, Caterina Socias, Isabel Mateu, Catalina Leiva, Alfonso Bejarano, Ferran Sempere, Ermengol Basora, Josep Palop, Vicente Mengual, Marta Beltran, Jose Luis Aragonès, Enric Lera, Guillem Folch, Silvia Piñol, Josep Lluís Esteva, Magdalena Roca, Miguel Arenas, Arturo del Mar Sureda, María Campoamor, Francisco Fiol, Francisca BMC Fam Pract Study Protocol BACKGROUND: Although benzodiazepines are effective, long-term use is not recommended because of potential adverse effects; the risks of tolerance and dependence; and an increased risk of hip fractures, motor vehicle accidents, and memory impairment. The estimated prevalence of long-term benzodiazepine use in the general population is about 2,2 to 2,6%, is higher in women and increases steadily with age. Interventions performed by General Practitioners may help patients to discontinue long-term benzodiazepine use. We have designed a trial to evaluate the effectiveness and safety of two brief general practitioner-provided interventions, based on gradual dose reduction, and will compare the effectiveness of these interventions with that of routine clinical practice. METHODS/DESIGN: In a three-arm cluster randomized controlled trial, general practitioners will be randomly allocated to: a) a group in which the first patient visit will feature a structured interview, followed by visits every 2-3 weeks to the end of dose reduction; b) a group in which the first patient visit will feature a structured interview plus delivery of written instructions to self-reduce benzodiazepine dose, or c) routine care. Using a computerized pharmaceutical prescription database, 495 patients, aged 18-80 years, taking benzodiazepine for at least 6 months, will be recruited in primary care health districts of three regions of Spain (the Balearic Islands, Catalonia, and Valencia). The primary outcome will be benzodiazepine use at 12 months. The secondary outcomes will include measurements of anxiety and depression symptoms, benzodiazepine dependence, quality of sleep, and alcohol consumption. DISCUSSION: Although some interventions have been shown to be effective in reducing benzodiazepine consumption by long-term users, the clinical relevance of such interventions is limited by their complexity. This randomized trial will compare the effectiveness and safety of two complex stepped care interventions with that of routine care in a study with sufficient statistical power to detect clinically relevant differences. TRIAL REGISTRATION: Current Controlled Trials: ISRCTN13024375 BioMed Central 2011-04-20 /pmc/articles/PMC3105938/ /pubmed/21507257 http://dx.doi.org/10.1186/1471-2296-12-23 Text en Copyright ©2011 Vicens et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Vicens, Caterina Socias, Isabel Mateu, Catalina Leiva, Alfonso Bejarano, Ferran Sempere, Ermengol Basora, Josep Palop, Vicente Mengual, Marta Beltran, Jose Luis Aragonès, Enric Lera, Guillem Folch, Silvia Piñol, Josep Lluís Esteva, Magdalena Roca, Miguel Arenas, Arturo del Mar Sureda, María Campoamor, Francisco Fiol, Francisca Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: A protocol for a clustered, randomized clinical trial |
title | Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: A protocol for a clustered, randomized clinical trial |
title_full | Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: A protocol for a clustered, randomized clinical trial |
title_fullStr | Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: A protocol for a clustered, randomized clinical trial |
title_full_unstemmed | Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: A protocol for a clustered, randomized clinical trial |
title_short | Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: A protocol for a clustered, randomized clinical trial |
title_sort | comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: a protocol for a clustered, randomized clinical trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105938/ https://www.ncbi.nlm.nih.gov/pubmed/21507257 http://dx.doi.org/10.1186/1471-2296-12-23 |
work_keys_str_mv | AT vicenscaterina comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT sociasisabel comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT mateucatalina comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT leivaalfonso comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT bejaranoferran comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT sempereermengol comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT basorajosep comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT palopvicente comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT mengualmarta comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT beltranjoseluis comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT aragonesenric comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT leraguillem comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT folchsilvia comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT pinoljoseplluis comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT estevamagdalena comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT rocamiguel comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT arenasarturo comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT delmarsuredamaria comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT campoamorfrancisco comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial AT fiolfrancisca comparativeefficacyoftwoprimarycareinterventionstoassistwithdrawalfromlongtermbenzodiazepineuseaprotocolforaclusteredrandomizedclinicaltrial |